Upstream Bio Inc.

6 clinical trials · Sponsor

Record	Firm	Date
A Study to Assess the Efficacy and Safety of Verekitug in Participants With COPD (NCT06981078)	Upstream Bio Inc.	2025-07-02
A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALIANT) (NCT06196879)	Upstream Bio Inc.	2024-02-27
A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Participants With Chronic Rhinosinusitis With Nasal Polyps (NCT06164704)	Upstream Bio Inc.	2023-12-18
Safety and Blood Levels After a Single Injection of UPB-101 in Healthy Japanese and Non-Japanese Non-East Asian Adults (NCT05653479)	Upstream Bio Inc.	2022-12-05
Safety and Biologic Impact (Pharmacodynamics) of Repeated Injections and Increasing Amounts of UPB-101 in Asthmatics (NCT05448651)	Upstream Bio Inc.	2022-07-08

Every clearance here is in the API, with alerts when new ones post.